Clinical relevance of anti-exenatide antibodies: safety, efficacy and cross-reactivity with long-term treatment

M.S. Fineman, K.F. Mace, M. Diamant, T. Darsow, B.B. Cirincione, T.K.B. Porter, L.A. Kinninger, M.E. Trautmann

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	546-554
Journal	Diabetes, Obesity and Metabolism
Volume	14
Issue number	6
DOIs	https://doi.org/10.1111/j.1463-1326.2012.01561.x
Publication status	Published - 2012

Access to Document

@article{6d92f7991cd240008038f937b612fb9a,

title = "Clinical relevance of anti-exenatide antibodies: safety, efficacy and cross-reactivity with long-term treatment",

author = "M.S. Fineman and K.F. Mace and M. Diamant and T. Darsow and B.B. Cirincione and T.K.B. Porter and L.A. Kinninger and M.E. Trautmann",

year = "2012",

doi = "10.1111/j.1463-1326.2012.01561.x",

language = "Undefined/Unknown",

volume = "14",

pages = "546--554",

journal = "Diabetes, Obesity and Metabolism",

issn = "1462-8902",

publisher = "Wiley-Blackwell",

number = "6",

}

TY - JOUR

T1 - Clinical relevance of anti-exenatide antibodies: safety, efficacy and cross-reactivity with long-term treatment

AU - Fineman, M.S.

AU - Mace, K.F.

AU - Diamant, M.

AU - Darsow, T.

AU - Cirincione, B.B.

AU - Porter, T.K.B.

AU - Kinninger, L.A.

AU - Trautmann, M.E.

PY - 2012

Y1 - 2012

U2 - 10.1111/j.1463-1326.2012.01561.x

DO - 10.1111/j.1463-1326.2012.01561.x

M3 - Article

C2 - 22236356

VL - 14

SP - 546

EP - 554

JO - Diabetes, Obesity and Metabolism

JF - Diabetes, Obesity and Metabolism

SN - 1462-8902

IS - 6

ER -